Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma

A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma

(2013) K.A. Thornton et al.   INTERNATIONAL JOURNAL OF CANCER

FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients

(2013) Paola Quarello et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia

(2013) John M. Goldberg et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma

(2013) Susanna J. E. Veringa et al.   PLoS One

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

(2011) K. J. Cohen et al.   NEURO-ONCOLOGY

Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts

(2010) Marianne Labussière et al.   ANTI-CANCER DRUGS

High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study

(2010) Johannes E. Wolff et al.   JOURNAL OF NEURO-ONCOLOGY

Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)

(2009) R.C.F. Leonard et al.   BREAST

Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study

(2008) A. C. Mertens et al.   JNCI-Journal of the National Cancer Institute

Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electrospray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies

(2007) Yanhong Liu et al.   TALANTA